Using a mouse xenograft tumor model, the authors demonstrated that the application of human anti-cathepsin D antibodies inhibited tumor growth by preventing macrophage recruitment and triggered natural killer cell activation [41]. The gene discussed is CTSD; the disease is neoplasm.